MARKET

ALPMF

ALPMF

Astellas Pharma
OTCPK
16.15
NaN%
Closed 09:30 04/10 EDT
OPEN
--
PREV CLOSE
15.91
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
67.86
52 WEEK LOW
10.78
MARKET CAP
28.93B
P/E (TTM)
14.05
1D
5D
1M
3M
1Y
5Y
1D
Astellas’ Menopause Drug Fezolinetant Hits Key Safety Milestone in Japan
TipRanks · 2d ago
Weekly Report: what happened at ALPMF last week (0330-0403)?
Weekly Report · 4d ago
ORIC Pharma drops after early-stage trial data for prostate cancer therapy
Seeking Alpha · 04/01 11:46
Astellas Highlights R&D Strategy While Flagging Market and Development Risks
TipRanks · 03/31 01:31
Weekly Report: what happened at ALPMF last week (0323-0327)?
Weekly Report · 03/30 09:59
Jefferies Keeps Their Buy Rating on Astellas Pharma (ALPMF)
TipRanks · 03/24 10:19
J.P. Morgan Sticks to Its Hold Rating for Astellas Pharma (ALPMF)
TipRanks · 03/23 10:16
Weekly Report: what happened at ALPMF last week (0316-0320)?
Weekly Report · 03/23 09:55
More
About ALPMF
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.

Webull offers Astellas Pharma Inc stock information, including OTCPK: ALPMF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALPMF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALPMF stock methods without spending real money on the virtual paper trading platform.